Junshi biological terminates its cooperation with AstraZeneca
On January 4, 2022, Junshi biology announced the termination of its promotion cooperation with AstraZeneca.
In February 28, 2021, the collaboration between Jun Shi and Ashley kangdacheng, exclusive application rights granted by the company of PD-1 to the trial of the urinary tract tumor in Chinese mainland, and the exclusive promotion right of all approved indications in non core city areas.
With the gradual maturity of the commercialization team built by Junshi biology, more indications of treprizumab injection have been successfully included in the latest version of the national medical insurance catalogue. In order to better implement the company's product commercialization promotion strategy in the next development stage and actively respond to the future market competition pattern, through friendly negotiation between the two sides, on December 31, 2021, Junshi biological signed the termination agreement of exclusive promotion agreement with AstraZeneca pharmaceutical, and Junshi biological officially withdrew the promotion right of treprizumab injection.
This text is a result of machine translation.
Related companies：
Briefing May 21, 2022 06:44 AM
· Financials
913 companies have been investigated by public funds since the second quarter, and the six top flow fund managers focus on the leaders of subdivided industries
In-depth
Consumer Staples
Exclusive Interview with Song Xiangqian, Founding Partner and Chairman of Harvest Capital
Harvest Capital invests in key fast-growing sectors dominated by large-sized players. Its portfolio includes snack giants Qiaqia Food (002557) (Chinese: 洽洽食品) and LYFEN (Chinese: 来伊份), energy drink startup Eastroc Beverage (605499) (Chinese: 东鹏饮料), Chinese fast-food chain Home Original Chicken (Chinese: 老乡鸡), top on-demand local delivery and retail platform Meituan Dianping (03690) (Chinese: 美团点评) and Chinese ride-sharing behemoth Didi (DIDI: NYSE) (Chinese: 滴滴出行).
Updated 2 hours ago
May 02, 2022 07:50 PM
Apr 28, 2022 08:00 PM
Apr 26, 2022 12:26 PM
Apr 25, 2022 01:02 PM
Briefing Apr 18, 2022 10:18 PM
· Technology
A number of enterprises on the science and innovation board are listed on the "white list" of key enterprises for operation guarantee and transfer
Financials, Healthcare
Ophthalmological Medtech Startup Raises Tens of Mns of CNY in Series C Funding
Founded in 2011, Suzhou Microclear Medical is engaged in the ophthalmology and optometry imaging field. Microclear integrates self-developed components with artificial intelligence technology to provide high-quality devices and services for hospitals and basic medical institutes across the world.
Updated 14 mins ago
Technology
China Launch Startup Orienspace Raises Nearly USD 60 Mn in Series A Round
Facing the explosive demand of various satellite networks, Orienspace innovatively builds the “Gravity” series of medium-and-large-sized commercial launch vehicles, achieving the economies of scale
May 21, 2022 07:50 PM
Briefing Feb 07, 2022 06:49 PM
· Healthcare
Fengtai District of Beijing will lift the epidemic prevention zone of the whole region from now on.
Technology
Smart Mining Truck Maker Easymove Raises Tens of Mns of CNY in Angel Round
With the development of new energy industry, huge opportunities existed in vehicle electrification under different mobile scenarios, and construction machinery is one of the largest potential markets
May 21, 2022 02:29 PM
In-depth
Technology
Exclusive Interview with Liu Di, Managing Director of Peakview Capital
“We thought this battle would be over in one or two years, but it has been dragging on for three years, so this could conversely be an opportunity for us to focus on; in other words, amid the unexpected international and domestic situation, new opportunities will be seen.”
May 21, 2022 12:51 PM
Briefing Jan 14, 2022 02:18 PM
· Healthcare
Hong Kong stocks continued to rise in the anti epidemic sector, and Junshi biology rose nearly 17%
Briefing Dec 31, 2021 01:08 PM
· Healthcare
Pharmaceutical and biological stocks continued to strengthen in the afternoon
Briefing Dec 27, 2021 09:49 AM
· Technology
The net purchase of 7 shares was more than 100 million yuan, and Ningde times was the most
See more
Read next
In-depth
In-depth
Technology
Exclusive Interview with Liu Di, Managing Director of Peakview Capital
May 21, 2022 12:51 PM
In-depth
In-depth
EqualOcean is an information service provider and investment research company that aims to become a global platform for industrial innovation. Founded in February 2014 and headquartered in Beijing, with a client network covering over 50 countries, the firm provides comprehensive professional services, including industry research, investment analysis, innovation consulting, data products, corporate branding and international strategy.